Cargando…
Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden
BACKGROUND: Glypican-1 (GPC1) is expressed in pancreatic ductal adenocarcinoma (PDAC) cells and adjacent stromal fibroblasts. Recently, GPC1 circulating exosomes (crExos) have been shown to be able to detect early stages of PDAC. In this study, we investigated the usefulness of crExos GPC1 as a biom...
Autores principales: | Frampton, Adam E., Prado, Mireia Mato, López-Jiménez, Elena, Fajardo-Puerta, Ana Belen, Jawad, Zaynab A.R., Lawton, Phillip, Giovannetti, Elisa, Habib, Nagy A., Castellano, Leandro, Stebbing, Justin, Krell, Jonathan, Jiao, Long R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922373/ https://www.ncbi.nlm.nih.gov/pubmed/29721179 http://dx.doi.org/10.18632/oncotarget.24873 |
Ejemplares similares
-
Prospective validation of microRNA signatures for detecting pancreatic malignant transformation in endoscopic-ultrasound guided fine-needle aspiration biopsies
por: Frampton, Adam E., et al.
Publicado: (2016) -
Impaired Autophagy Response in Hepatocellular Carcinomas Enriches Glypican-3 in Exosomes, Not in the Microvesicles
por: Koksal, Ali Riza, et al.
Publicado: (2022) -
Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR
por: Castellano, Leandro, et al.
Publicado: (2017) -
MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors
por: Jiao, Long R., et al.
Publicado: (2012) -
The clinical significance of tumor infiltrating lymphoctyes in breast cancer: does subtype matter?
por: Krell, Jonathan, et al.
Publicado: (2012)